Search results
Researchers discover new target for potential leukemia therapy
Medical Xpress· 5 days agoThe study provides both mechanistic and preclinical evidence supporting the rapid initiation of...
Older adults with aggressive blood cancer are responsive to treatment and show prolonged survival:...
Medical Xpress· 4 days agoStandard of care treatment for acute myeloid leukemia (AML) is safe and effective for adults over...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 9 hours agoPomerantz LLP announces that a class action lawsuit has been filed against bluebird bio, Inc. (“bluebird” or the “Company”) (NASDAQ: BLUE). Such investors are advised to contact Danielle Peyton ...
Danbury High runner who was on death bed with cancer graduates from Sacred Heart: 'Very determined'
The News-Times· 2 days agoIn May 2019, 21-year-old Alex Chakar was diagnosed with acute myeloid leukemia and within a few...
Curis to Present Updated Data from the TakeAim Leukemia Study
WPRI Providence· 3 days ago(NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today announced that the Company will present ...
ExxonMobil Hit with $725M Verdict for Failure to Warn About Cancer-Causing Benzene in Gasoline
Morningstar· 3 days agoA Philadelphia jury has returned a $725.5 million verdict against ExxonMobil, finding the company's failure to warn about known health risks of exposure to cancer-causing benzene in its petroleum ...
GlycoMimetics (NASDAQ:GLYC) Downgraded to Equal Weight at Capital One Financial
ETF DAILY NEWS· 5 days agoCapital One Financial lowered shares of GlycoMimetics (NASDAQ:GLYC – Free Report) from an overweight rating to an equal weight rating in a research report sent to investors on Monday morning ...
TC BioPharm Announces Exercise of Warrants for £3.1 Million Gross Proceeds
Morningstar· 6 days agoTC BioPharm (Holdings) plc ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer, today ...
Syros Pharmaceuticals (SYRS) Set to Announce Quarterly Earnings on Tuesday
ETF DAILY NEWS· 1 day agoSyros Pharmaceuticals (NASDAQ:SYRS – Get Free Report) is scheduled to release its earnings data before the market opens on Tuesday, May 14th. Analysts expect Syros Pharmaceuticals to post earnings ...
Deerfield Management and Deerfield Foundation Announce Second Annual AML Summit and Recipients of...
The Pilot News· 7 days agoDeerfield Management and the Deerfield Foundation announced today they will honor the 2023-2024 recipients of the American Society of Hematology (ASH) Peter Steelman Scholar Award at the second ...